![]() |
市场调查报告书
商品编码
1600972
感染疾病体外诊断市场:按产品、技术、适应症和最终用户划分 - 2025-2030 年全球预测Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Global Forecast 2025-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2023年,感染疾病体外诊断市值为490.6亿美元,预计到2024年将达到525.1亿美元,复合年增长率为7.22%,到2030年将达到799.5亿美元。
感染疾病体外诊断(IVD)市场范围包括对血液、组织和其他体液等样本进行诊断测试,以检测人体内的感染疾病。由于全球感染疾病爆发次数不断增加、对快速诊断解决方案的需求不断增加以及 COVID-19 等流行病的持续威胁,该市场变得至关重要。这些诊断对于及时、准确的诊断、促进适当的治疗计划和管理、从而挽救生命和减少疾病传播至关重要。最终用途包括检测爱滋病毒、流感、结核病、肝炎、新兴感染疾病等,并包括医院、临床实验室和照护现场。市场成长受到次世代定序、PCR 和免疫测量等技术进步的显着影响,这些技术进步提高了准确性和速度。利用人工智慧和机器学习来解释诊断结果的新颖用途也带来了显着的机会。此外,在便利性、结果即时解释和隐私的推动下,人们对家庭测试的日益重视,正在该行业中开闢出一个重要的利基市场。然而,先进诊断技术的高价格、监管障碍以及新兴市场有限的医疗基础设施等挑战正在限制市场扩张。由于某些测试中的技术限製而导致的不可靠结果也可能成为阻碍力。技术创新的关键领域是开发价格实惠、简单且高度灵敏的携带式诊断仪。此类创新可以大大提高可及性,尤其是在世界资源匮乏的环境中。此外,寻找新疾病的生物标记以及同时针对多种病原体的多重测试的扩展可能会改变游戏规则。随着新的传染性威胁的频繁出现,这个市场的性质是高度动态的,需要技术提供者和医疗保健专业人员之间持续的研究和开发投资以及合作,以保持熟练的应对力。利用市场机会的建议包括策略伙伴关係和对研发的大力投资,以开发更有效、更便宜的诊断方法。
主要市场统计 | |
---|---|
基准年[2023] | 490.6亿美元 |
预测年份 [2024] | 525.1亿美元 |
预测年份 [2030] | 799.5亿美元 |
复合年增长率(%) | 7.22% |
市场动态:快速发展的感染疾病体外诊断市场的关键市场洞察
感染疾病体外诊断市场正因供需之间的动态互动而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。
波特五力:引领感染疾病体外诊断市场的策略工具
波特的五力架构是了解感染疾病体外诊断市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。
PESTLE分析:了解外部对感染疾病体外诊断市场的影响
外部宏观环境因素在塑造感染疾病体外诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并为他们做出积极主动的决策做好准备。
市场占有率分析 了解感染疾病体外诊断市场的竞争状况
对感染疾病体外诊断市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。
FPNV定位矩阵感染疾病体外诊断市场供应商绩效评估
FPNV定位矩阵是评估感染疾病体外诊断市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商,帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。
1. 市场渗透率:对当前市场环境的详细回顾,包括行业主要企业的大量资料。
2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。
3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。
4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。
5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。
1.目前的市场规模和未来的成长预测是多少?
2. 哪些产品、区隔市场和地区提供最佳投资机会?
3.塑造市场的主要技术趋势和监管影响是什么?
4.主要厂商的市场占有率和竞争地位如何?
5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?
The Infectious Diseases In-Vitro Diagnostics Market was valued at USD 49.06 billion in 2023, expected to reach USD 52.51 billion in 2024, and is projected to grow at a CAGR of 7.22%, to USD 79.95 billion by 2030.
The scope of the infectious diseases in-vitro diagnostics (IVD) market encompasses diagnostic tests performed on samples such as blood, tissue, and other body fluids to detect infectious diseases within the human body. This market has become essential due to rising global infectious disease prevalence, increasing demand for rapid diagnostic solutions, and the ongoing threat of pandemics like COVID-19. These diagnostics are imperative for timely and accurate diagnosis, facilitating proper treatment plans and management, thus saving lives and curbing disease spread. Key applications involve testing for diseases such as HIV, influenza, tuberculosis, hepatitis, and emerging infections, with end-use sectors including hospitals, clinical laboratories, and point-of-care settings. Market growth is significantly influenced by technological advancements like next-generation sequencing, PCR, and immunoassays leading to improved accuracy and speed. The novel use of AI and machine learning for interpreting diagnostic results also presents noteworthy opportunities. Furthermore, the growing emphasis on home testing, fueled by convenience, immediate result interpretation, and privacy, is carving a significant niche within this industry. However, challenges such as high costs of advanced diagnostics, regulatory hurdles, and limited healthcare infrastructure in developing regions restrain market expansion. Also, unreliable results due to technical limitations in specific tests can be a deterrent. A key area for innovation lies in the development of affordable, simple, yet highly sensitive portable diagnostics. These innovations can dramatically enhance accessibility, particularly in low-resource settings worldwide. Also, exploring biomarkers for novel diseases and expanding multiplex testing, which simultaneously targets multiple pathogens, can be game-changers. The nature of this market is highly dynamic, driven by the frequent emergence of new infectious threats, thus requiring continuous R&D investment and collaboration between technology providers and healthcare professionals to stay adept and responsive. Recommendations for capitalizing on market opportunities include strategic partnerships and robust investments in R&D to cultivate more effective, less expensive diagnostics.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 49.06 billion |
Estimated Year [2024] | USD 52.51 billion |
Forecast Year [2030] | USD 79.95 billion |
CAGR (%) | 7.22% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infectious Diseases In-Vitro Diagnostics Market
The Infectious Diseases In-Vitro Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
Porter's Five Forces: A Strategic Tool for Navigating the Infectious Diseases In-Vitro Diagnostics Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infectious Diseases In-Vitro Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Infectious Diseases In-Vitro Diagnostics Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infectious Diseases In-Vitro Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Infectious Diseases In-Vitro Diagnostics Market
A detailed market share analysis in the Infectious Diseases In-Vitro Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infectious Diseases In-Vitro Diagnostics Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infectious Diseases In-Vitro Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Key Company Profiles
The report delves into recent significant developments in the Infectious Diseases In-Vitro Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Trinity Biotech PLC, Qiagen N.V., DiaSorin S.p.A, Koninklijke Philips N.V., Vela Diagnostics, InBios International, Inc., PerkinElmer, Inc., Quest Diagnostics, F. Hoffmann La-Roche Ltd., bioMerieux SA, Laboratory Corporation Of America Holdings, Sysmex Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Grifols, S.A., Hologic, Inc., Siemens Healthineers AG, Danaher Corporation, Quidel Corporation, Epitope Diagnostics, Inc., Genspeed Biotech GmbH, Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Uniogen Oy, DX Lab Inc., Illumina, Inc., OraSure Technologies, Inc., Merck KGaA, and Becton, Dickinson and Company.
Market Segmentation & Coverage
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?